Robert C Leinbach

Title: The Innovations of Robert C. Leinbach in Vascular Treatments

Introduction

Robert C. Leinbach, a notable inventor based in Brookline, MA, has made significant contributions to the field of vascular treatments. With one patent to his name, he has focused on methods for treating vascular stenosis, demonstrating his commitment to enhancing medical procedures through innovation.

Latest Patents

Leinbach's patent, titled "Methods and Compositions for Treating Vascular Stenosis," outlines innovative techniques for treating this condition using hepatocyte growth factor (HGF). The patent details methods by which HGF can be administered to promote the healing and re-surfacing of blood vessels that have been damaged, particularly in the aftermath of surgical procedures such as vascular surgery or angioplasty. Additionally, the patent includes articles of manufacture and kits that contain HGF, showcasing a practical application of his research.

Career Highlights

Throughout his career, Robert C. Leinbach has worked at prominent organizations including Genentech, Inc. and The General Hospital Corporation. His tenure at such esteemed institutions has allowed him to refine his skills and further his research in the biomedical field.

Collaborations

Leinbach has collaborated with esteemed colleagues in the industry, including Stuart Bunting and Herman K. Gold. These partnerships have undoubtedly enriched his work and contributed to the successful development of his patent.

Conclusion

Robert C. Leinbach's patent and his work in the field of vascular treatment reflect his dedication to medical innovation. His research not only addresses the crucial issue of vascular stenosis but also sets the stage for future advancements in treatment methodologies. With a focus on enhancing patient outcomes, Leinbach remains an important figure in the world of medical inventions.